Table 2.
ANS components in patients with FD
| total (n = 45) |
EPS (n = 21) |
PDS (n = 24) |
|||||||
|---|---|---|---|---|---|---|---|---|---|
| HF | LF/HF | HF | LF/HF | HF | LF/HF | ||||
| 24 h | Increased | 2 (4.4%) | 23 (51.1%) | 0 | 10 (47.6%) | 2 (8.3%) | 13 (54.2%) | ||
| Decreased | 39 (86.7%) | 13 (28.9%) | 18 (85.7%) | 8 (38.1%) | 21 (87.5%) | 5 (20.8%) | |||
| Normal | 4 (8.9%) | 9 (20.0%) | 3 (14.3%) | 3 (14.3%) | 1 (4.2%) | 6 (25.0%) | |||
| Daytime | Increased | 1 (2.2%) | 33 (73.3%) | 0 | 14 (66.7%) | 1 (4.2%) | 19 (79.2%) | ||
| Decreased | 44 (97.8%) | 8 (17.8%) | 21 (100%) | 5 (23.8%) | 23 (95.8%) | 3 (12.5%) | |||
| Normal | 0 | 4 (8.9%) | 0 | 2 (9.5%) | 0 | 2 (8.3%) | |||
| Nighttime | Increased | 6 (13.3%) | 12 (26.6%) | 2 (9.5%) | 4 (19.0%) | 4 (16.7%) | 8 (33.3%) | ||
| Decreased | 30 (66.7%) | 26 (57.8%) | 15 (71.5%) | 14 (66.7%) | 15 (62.5%) | 12 (50.0%) | |||
| Normal | 9 (20.0%) | 7 (15.6%) | 4 (19.0%) | 3 (14.3%) | 5 (20.8%) | 4 (16.7%) | |||
EPS, epigastric pain syndrome; PDS, postprandial syndrome; HF, high-frequency; LF, low-frequency.